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In the past, health care was delivered mainly in acute-care facilities. Today, health care is delivered in
hospital, outpatient, transitional care, long-term care, rehabilitative care, home, and private office settings.
Measures to reduce health-care costs include decreasing the number of hospitals and the length of patient
stays, increasing outpatient and home care, and increasing long-term care for the elderly. The home-care
industry and managed care have become major providers of health care. The role of specialists in health-
care epidemiology has changed accordingly.
Over the past two decades, there has been a revolution in
health-care delivery systems in the United States. The
number of acute-care facilities has decreased, the proportion
of patients requiring intensive care in acute-care facilities has
increased, and the number of surgical procedures performed
in outpatient settings or surgical centers has increased. Not
only has there been a shift to the outpatient setting, but the
long-term care, home-care, and managed-care industries
have grown dramatically. I will provide an overview of recent
changes in the U.S. health-care delivery system and describe
the challenges for health-care epidemiology and infection
control departments in the new millennium.
Changing Spectrum of
Health-Care Delivery
In the 1970s and 1980s, the acute-care facility was the
center of the hospital infection and infection control universe
(1) (Figure 1). Most health care was delivered in the acute-
care setting, and outpatient, long-term, and home care were
relatively small, in number of facilities and patients. The
growth of the U.S. gross domestic product (GDP) and the
proportion spent on health care reflect changes in health-care
delivery (Figure 2). From 1960 to 2000, the GDP grew nearly
15-fold, from approximately $526 billion to nearly $8,000
billion. At the same time, the proportion of the GDP expended
on health care increased 41% to approximately $1,120 billion.
This growth, together with the introduction of the prospective
payment plan based on diagnostic-related groups, led to
marked changes in hospitalization (Table 1). From 1975 to
1995, the number of hospitals decreased from 7,126 to 6,291,
the number of hospital beds decreased from 1.47 million to
1.08 million, patient admissions decreased by 5%, hospital
stay decreased by 36%, the average length of patient stay
decreased by 33%, and the number of inpatient surgical
procedures decreased by 27%. These trends have resulted in
fewer and smaller hospitals, more and larger intensive care
units, and greater severity of illness in the hospitalized
population. At the same time, reports of nursing shortages
and downsizing of infection control departments have been
increasing, despite the fact that nearly 2 million hospital-
acquired infections occur each year. Thus, the challenge for
infection control departments in acute-care settings will be to
focus surveillance activities on populations at high risk,
calculate risk-adjusted rates of hospital-acquired infection,
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Figure 1. Health-care system of the past, 1970–1980
Figure 2. Distribution of U.S. gross domestic product (GDP) and
proportion of GDP distributed as national health-care expenditures,
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Table 1. Changing epidemiology of health care in acute-care facilities
Year
Characteristic 1975 1995
Admissions   37,700,000   35,900,000
Patient-days 299,000,000 190,000,000
Length of stay    7.9 days    5.3 days
Inpatient surgical procedure   18,300,000   13,300,000
Adapted from reference 6 and unpublished data (CDC, Hospital
Infections Program)
Figure 3. Number of nursing homes and nursing-home beds in the
United States, 1976–1996. (Adapted from reference 5).
and provide feedback to appropriate personnel so that
integrated prevention programs can be implemented and
interventions evaluated to ensure quality health care (2-4).
Effects of the Aging Population
Since 1950, the number of persons >65 years of age in the
United States has nearly tripled, from 12.2 million to 36
million. To accommodate this growth, the number of nursing
homes increased from 16,091 in 1986 to 17,208 in 1996, and
the number of beds in these facilities increased from 1.298
million to 1.839 million (Figure 3) (5). By 2035, the population
of persons  65 years of age will exceed 80 million. In 1997, 1.6
million persons lived in long-term care facilities; by 2005, this
figure will increase to an estimated 5 million. Since 3%-15% of
such patients acquire an infection in these facilities each year,
the 48,000 to 240,000 infections estimated to have occurred in
1997 will increase to an estimated 150,000 to 750,000 in 2005.
Challenges for infection control in long-term care
facilities include the following: First, many facilities have no
dedicated infection control personnel to conduct surveillance
and lead prevention, education, and intervention programs.
Second, uniform definitions and surveillance protocols are
needed for infections acquired in long-term care facilities.
Third, further studies are needed to determine the best
numerator (e.g., number of infections, colonization, positive
cultures, symptomatic or asymptomatic residents) and
denominator (e.g., number of residents, number of resident-
days, number of residents with a specific device or device-
days) to use for infection rate calculations to facilitate inter-
and intrafacility comparisons. Fourth, for many reasons,
including lack of availability of laboratory facilities, failure of
clinicians to order appropriate diagnostic work-ups, and
inadequate reimbursement for diagnostic testing for
infections, patients in long-term care facilities often are not
evaluated for infection when they are symptomatic. (Rather,
antimicrobial drugs are initiated on an empiric basis.) The
influence of this reduced testing on detection of infections
acquired in long-term care facilities needs to be assessed.
Emergence of Home Health-Care Delivery
The fastest-growing segment of the health-care delivery
system has been the home health business. In 1988, the
Health Care Financing Administration expended approximate-
ly $2 billion for home health. By 1999, approximately $20 billion
was expended.  Today, almost as many persons receive health
care in the home (an estimated 34 million annually) as in
acute-care settings.
Infection control in home-care settings poses the
following challenges: 1) Few home health-care companies
have dedicated infection control personnel. 2) No uniform
definitions of infection or protocols for infection surveillance
have been agreed upon. 3) Often health-care delivery in the
home is uncontrolled and may even be provided by family
members. 4) Health Care Financing Administration
reimbursement schedules largely determine policies on the
frequency of home health-care visits. 5) For some infection
rates, such as central venous catheter-associated bloodstream
infections, device-adjusted rates are needed for intra- and
interfacility and company comparisons. Who will collect these
data? How will the numerator (number of infections) be
captured when the data may come from various sources,
including the hospital, private physician offices, or private
laboratories? Often these data are not reported to the home
health-care company and thus may be very difficult to obtain.
Although collecting these data from a single home health-care
company is easier, many acute-care facilities contract with 10
to 20 home health-care companies and do not require in their
contracts that such data (numerator, denominator, or rates)
be provided. Thus, further studies are necessary to determine
the data critical for measuring the quality of home health-
care delivery and to identify which components of our
infection control programs are essential.
At least initially, home health care and other infection
control personnel should focus their efforts on high-risk
infections, e.g., urinary tract, bloodstream, pneumonia, or
skin and soft tissue infections. For specific infections, e.g.,
urinary tract and bloodstream infections, device-specific
infection rates should be calculated. Uniform definitions
applicable to home care, uniform surveillance protocols, and a
national nonpunitive reporting system should be established
so that rates can be compared.
Growth of Health Maintenance Organizations
Since 1976, managed care and health maintenance
organizations in the United States have grown explosively. In
1976, there were approximately 174 health maintenance
organizations in the United States (Figure 4) (5). By 2000,
that number had grown to >700. Concomitantly, the number
of persons enrolled in such plans increased from 6 million to
>75 million, and the percentage of the U.S. population
enrolled in such plans increased tenfold, from 2.8% to 29%.
Because managed-care organizations focus their efforts on
cost containment, the challenge for infection control
personnel will be to demonstrate to administrative personnel
that both quality care and cost containment are facilitated by
improving infection surveillance and control programs.
Outpatient and Ambulatory Care
From 1993 to 1996, the annual number of visits to
hospital outpatient clinics increased from 62.5 million to 67.1
million, the number of hospital emergency department visits
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of physician office visits increased from 717 million to 734
million. Challenges for infection control personnel in
outpatient and ambulatory-care settings include determining
for which infections to conduct surveillance, what definitions
to use, who will conduct the surveillance, to whom the data
will be reported, and who will be responsible for
implementing the changes. Often infection control personnel
are not aware of what populations of patients are being seen
or what procedures are being performed in outpatient
settings. Furthermore, no systems are in place to collect the
needed numerators (infections or adverse events) and
denominators (e.g., number of patients with central venous
catheters being seen in the clinic) data. To collect the data for
these rate calculations, it will be necessary to identify
methods, including electronic databases, whereby such data
can be captured and used. Calculating infection or adverse
event rates in outpatients and reporting them to ambulatory
care and specialty personnel (e.g., the director of the oncology
clinic) will be useful for improving education programs for
health-care workers, as well as the quality of patient care.
Role of the Infection Control Professional
Infection control personnel play a critical role in
preventing infections and medical errors. They conduct
infection surveillance in acute-care facilities, apply standard
definitions and surveillance protocols, calculate infection
rates, report these data to essential personnel, implement
prevention interventions, and evaluate their impact. Most
importantly, as the Study of the Efficacy of Infection Control
Programs (SENIC) has documented, the infection surveil-
lance and prevention efforts of these infection control
personnel are cost-effective (6).
Increasingly, infection control personnel have been
expanding their activities to include prevention of infection
and other adverse events in long-term care, home-care, and
outpatient  settings. If we are to prevent infections and
other adverse events associated with the delivery of health
care in the entire spectrum of health-care settings, we will
need to expand the infection control departments in all
these settings (Figure 5).
Figure 4. Growth of health maintenance organization (HMO) plans, enrollees, and percent of U.S. population enrolled in HMOs, 1976-2000.
(Adapted from reference 5).
Figure 5. Model for comprehensive surveillance and prevention of
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Conclusions
Over the past two decades, acute-care facilities have
become smaller and fewer, but the hospitalized patient
population has become more severely ill and more
immunocompromised and thus at greater risk for hospital-
acquired infections. At the same time, the proportion of the
U.S. population  >65 years of age has increased, as have the
number of long-term care facilities and the number of beds in
these facilities. This trend is expected to continue for the next
50 years. Similarly, delivery of health care in the home has
become the most rapidly growing sector of the health-care
system. Currently, nearly as many patients are receiving care
in the home as in the inpatient setting. Provision of health
care in managed-care and outpatient and ambulatory-care
settings continues to expand. Thus, the spectrum of health-
care delivery in 2000 is larger than ever before. Because of the
severely ill and immunocompromised populations in these
settings, prevention of infections and other adverse events
is a major component of providing quality care.
In each of these settings, challenges need to be addressed.
In acute-care settings, where the responsibilities of infection
control departments already have markedly expanded (e.g.,
occupational health, prevention exposure to bloodborne
pathogens, prevention of Mycobacterium tuberculosis or
multidrug-resistant bacterial transmission, medical errors)
during the past 2 decades, emphasis will need to be on
conducting surveillance of populations at high risk,
calculating device-specific infection rates, and educating
health-care workers on infection control. In long-term care
facilities, infection control personnel need to establish
infection surveillance systems, determine baseline infection
rates for comparison, improve device and antimicrobial drug
use, and educate staff about prevention. In managed-care
settings, infection control personnel will need to expand their
efforts toward cost-effective infection surveillance and control
programs. In the outpatient and ambulatory setting, infection
control personnel will need to work with computer systems
and clinic personnel to design information systems to improve
collection of data about infections and other adverse events so
that rates can be calculated and trends monitored. Because of
their expertise in epidemiologic methods, infection control
personnel can assist infection control, quality assurance, and
medical error reduction programs in all these health-care
system components.
Infection control personnel will need to expand their
efforts to match the expansion of the health-care delivery
system. Enhanced administrative support for programs to
prevent infections and medical errors will be needed if we are
to reduce the risk of infection and other adverse events and
improve the quality of care in the entire spectrum of health-
care delivery. Now, instead of the acute-care facility being the
center of the infection control universe, the infection control
department has become the center of the diverse health-care
delivery system. Infection control departments will need to
expand their surveillance of infections and adverse events
and their prevention efforts to all settings in which health
care is delivered.
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